AI医疗利好不断，AI医疗含量超20%的港股通医疗ETF（520510）重磅上市

Core Viewpoint - The approval of the "Opinions on Deepening the Implementation of the 'Artificial Intelligence+' Action" injects strong policy momentum into the research and development of AI in healthcare [1] Group 1: Policy and Market Opportunities - The continuous release of policy dividends brings strategic opportunities to the AI healthcare sector, which is expected to attract more investment attention [1] - AI healthcare, as a core area of artificial intelligence application, has vast development potential according to Southwest Securities [1] Group 2: Technological Advancements and Investment Tools - The application boundaries of AI in healthcare are expanding, covering cutting-edge fields such as pharmaceutical intelligence and showing significant potential in critical clinical areas like early screening for rare diseases [1] - The Hong Kong Stock Connect medical ETF (520510), which has over 20% AI healthcare content, provides a new investment tool for investors to capitalize on the "anti-involution" dividend in the pharmaceutical industry and the main line of AI healthcare [1]